Christian Manegold Nick Thatcher Christian Manegold, Heidelberg University Medical Center, Manheim Nick Thatcher, Christie Hospital, Manchester Is bevacizumab a new standard of care for patients with
Christian Manegold
Nick ThatcherChristian Manegold, Heidelberg University Medical Center, ManheimNick Thatcher, Christie Hospital, Manchester
Is bevacizumab a new standard of care for patients with unresectable non-small cell lung cancer who have good performance status? This question was raised in a debate at the European Congress on Lung Cancer held in Turin.Christian Manegoldprovided delegates with evidence from the AVAil and ECOG 4599 studies which underpin current approval of this anti-vascular endothelial growth factor (VEG-F) antibody.Nick Thatcherpointed out the limitations. They both talked with Peter Goodwin.